Search

for
Search:

Research

5 / 1000+ results

research Results of stage I in a phase II randomized bilateral comparison of bexarotene 1% topical gel in alopecia areata

March 2005 in “Journal of the American Academy of Dermatology”

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

research Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial

2 citations , November 2025 in “Journal of the American Academy of Dermatology”

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

research Small cell lung cancer: Results of a phase II study of 1,2,4 triglycidylurazol

6 citations , May 1986 in “Cancer Chemotherapy and Pharmacology”

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Safety and Efficacy of a Topical Treatment (SM04554) for Androgenetic Alopecia: Results from a Phase 1 Trial

research Safety and efficacy of a topical treatment (SM04554) for androgenetic alopecia (AGA): Results from a phase 1 Trial

2 citations , April 2016 in “Journal of The American Academy of Dermatology”

Dutasteride more effective than finasteride for hair growth; SM04554 safe and potentially effective for hair loss.

research Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata

44 citations , October 2009 in “Journal of the American Academy of Dermatology”

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

View more "phase 1 results" in research →

Community Join

5 / 1000+ results

community KX-826 1% Phase II Results from China Just Dropped

in Research/Science 37 upvotes 11 months ago

KX-826 (Pyrilutamide) 0.5% and 1.0% solutions showed promising results in increasing hair count for male androgenetic alopecia, with the 0.5% dose slightly outperforming the 1% dose. The treatment was well-tolerated with no sexual side effects, but skepticism remains due to past inconsistencies in trial results.

community (1 month pyrilutamide results) what I noticed: massive shedding phase around week 2. it was worse than finasteride and minoxidil shedding. no side effects other than headache the first time I applied it. I feel like it's working but still too soon to tell.

in Research/Science 5 upvotes 3 years ago

The user experienced significant hair shedding in the second week of using pyrilutamide, more so than with finasteride and minoxidil, and reported a headache after the first application. They believe the treatment may be working but acknowledge it's too early to confirm results.

community PP405 Hair Loss Drug: Phase 1 Human Results & Biopsy Insights

in Research/Science 215 upvotes 1 year ago

PP405 is a potential hair loss treatment undergoing trials, with discussions on its effectiveness and comparison to existing treatments like finasteride and minoxidil. There is skepticism about its status as a cure, with hopes for future advancements in genetic treatments like CRISPR.

community ICYMI: Eirion ET-02’s Successful Phase 1 Trial Results for Androgenic Alopecia Treatment

in Treatment 48 upvotes 1 year ago

ET-02 showed significant hair growth in five weeks, outperforming minoxidil, with a non-hormonal mechanism that avoids side effects of treatments like finasteride. A phase 2 trial is planned to further assess ET-02's efficacy and safety.

community Where can I find the results of GT20029 phase 1 study in the US/China. The actual data

in Technology 5 upvotes 2 years ago

The conversation is about someone looking for specific side effects reported in clinical trials for GT20029, a hair loss treatment. No results or data were found on the clinical trials site.

View more "phase 1 results" in community →